Back to search
HER2-positive Locally Advanced Resectable Gastric Cancer
Clinical trial pipeline · Data from ClinicalTrials.gov
See which HER2-positive Locally Advanced Resectable Gastric Cancer trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which HER2-positive Locally Advanced Resectable Gastric Cancer trials you may qualify forThis is a phase II, multicenter, randomized, open-label study designed to evaluate the efficacy and safety of perioperative trastuzumab+XELOX with / without ate…
This study is designed to evaluate the safety and efficacy of JSKN003 combination therapy as first-line treatment in HER2-positive unresectable locally advanced…
The purpose of this study is to determine the rate of complete pathological responses (percentage of patients with pCR referring to the total number of enrolled…